Related Experiment Videos
Genetics of chronic obstructive pulmonary disease
Dawn L DeMeo1, Edwin K Silverman
1Channing Laboratory, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Seminars in Respiratory and Critical Care Medicine
|August 10, 2005
Summary
Genetic factors influence chronic obstructive pulmonary disease (COPD) susceptibility. While severe alpha 1-antitrypsin (AAT) deficiency is a known risk, genetic modifiers likely explain lung function variability in COPD development.
Area of Science:
- Pulmonary Medicine
- Genetics
- Environmental Health
Background:
- Chronic obstructive pulmonary disease (COPD) susceptibility is influenced by genetic and environmental factors.
- Severe alpha 1-antitrypsin (AAT) deficiency (protease inhibitor Z) is the only established genetic risk for COPD.
- Variability in lung function among individuals with severe AAT deficiency suggests the presence of genetic modifiers.
Purpose of the Study:
- To explore the genetic underpinnings of COPD susceptibility beyond severe AAT deficiency.
- To investigate genetic influences on lung function trajectories and COPD development.
- To address inconsistencies in previous candidate gene association studies for COPD.
Main Methods:
- Review of genetic association studies investigating candidate COPD gene loci.
- Analysis of linkage studies to identify genomic regions associated with COPD susceptibility.
- Discussion of potential reasons for conflicting results in association studies, including genetic heterogeneity and population stratification.
Main Results:
- Inconsistent results are common in candidate gene association studies for COPD.
- Severe AAT deficiency is the only confirmed genetic risk factor for COPD.
- Linkage analysis studies are emerging as a method to identify COPD susceptibility genes.
Conclusions:
- Genetic heterogeneity and population stratification may explain conflicting findings in COPD genetic association studies.
- Family-based designs and linkage analysis are recommended for future COPD genetic research.
- Identifying genetic modifiers is crucial for understanding COPD variability, even in severe AAT deficiency.